Get started
Author

Elliot J. Hogg

Observed names: E J Hogg, Elliot Hogg, Hogg, Elliot
ORCID: 0000-0002-0287-142X
Observed ORCID: 0000-0002-0287-142X
OpenAlex ID: A5063923498
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study
2024 · Ana Westenberger, Volha Skrahina, et al. · Brain · 106
PDF
High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease
2018 · Elliot Hogg, Kishore Athreya, et al. · Journal of Parkinson s Disease · 91
A Phase II, Randomized, Double-Blinded, Placebo-Controlled Trial of Liraglutide in Parkinson's Disease
2022 · Elliot Hogg, Tina Wu, et al. · SSRN Electronic Journal · 52
Three‐dimensional simultaneous brain mapping of T1, T2, and magnetic susceptibility with MR Multitasking
2021 · Tianle Cao, Sen Ma, et al. · Magnetic Resonance in Medicine · 40
Deep Brain Stimulation and Nonmotor Symptoms
2017 · Elliot Hogg, Jeffrey Wertheimer, et al. · International review of neurobiology · 33
Liraglutide Improves Non-Motor Function and Activities of Daily Living in Patients with Parkinson’s disease: A Randomized, Double-Blind, Placebo-Controlled Trial (P9-11.005)
2022 · Camille Malatt, Tina Wu, et al. · Neurology · 30
Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy
2022 · Predrag Jovanovic, Yidan Wang, et al. · PLoS ONE · 20
PDF
Sustained quality‐of‐life improvements over 10 years after deep brain stimulation for dystonia
2018 · Elliot Hogg, Emmanuel During, et al. · Movement Disorders · 16
The role of Personal KinetiGraph™ fluctuator score in quantifying the progression of motor fluctuations in Parkinson's disease.
2019 · E E Tan, E J Hogg, et al. · PubMed · 9
Head drop in Parkinson's disease complicated by myasthenia gravis and myopathy
2017 · Elliot J. Hogg, Richard A. Lewis, et al. · Journal of the Neurological Sciences · 8
Overuse Cervical Dystonia: A Case Report and Literature Review
2016 · Elliot Hogg, Michele Tagliati · Tremor and Other Hyperkinetic Movements · 8
Adrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson’s disease
2025 · Camille Malatt, Helia Maghzi, et al. · Journal of Neurology · 7
Overuse Cervical Dystonia: A Case Report and Literature Review
2016 · Hogg, Elliot, Tagliati, Michele · PubMed · 3
Substantia nigra segmentation on neuromelanin-sensitive MRI
2019 · Touseef Ahmad Qureshi, Elliot Hogg, et al. · SPIE Medical Imaging: Biomedical Applications in Molecular, Structural, and Functional Imaging · 2
Adrenoceptor agonists and antagonists and risk of Parkinson's disease
2019 · Helia Maghzi, Elliot J. Hogg, et al. · Movement Disorders · 2
2 A Randomized, Double-blinded, Placebo-controlled Trial of Liraglutide in Patients with Parkinson’s Disease: Neuropsychological Outcomes
2023 · Jeffrey C Wertheimer, Elliot Hogg, et al. · Journal of the International Neuropsychological Society · 1
PDF
Evidence of Sympathetic Overactivity in Subjects with REM Behavior Disorder at Risk for Parkinson’s Disease (P6-13.002)
2023 · Michele Tagliati, Michele Gregorio, et al. · Neurology
Reversible MIBG Abnormalities In subjects at risk for Synucleinopathy (2947)
2021 · Helia Maghzi, Elliot Hogg, et al. · Neurology
Glycated Hemoglobin Levels are Inversely Correlated with FDG-PET Uptake in Non-diabetic Patients with Parkinson’s Disease (4632)
2021 · Elliot Hogg, Helia Maghzi, et al. · Neurology
Works count: 19
Citation count: 428
H-index: 9
I10-index: 8
Year
Topic
Type